2013
DOI: 10.1016/j.biocel.2013.07.006
|View full text |Cite
|
Sign up to set email alerts
|

miR-320a regulates erythroid differentiation through MAR binding protein SMAR1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 42 publications
0
11
0
Order By: Relevance
“…Notably, miR-222, miR-34a, miR-371a, Bax, Cyclin D1, NFκB, CD40, FN1 and PDGFRB genes showed presence of S/MAR within 1 Kb region upstream to their transcription start sites (TSS). Presence of S/MARs in the promoters of these genes has already been demonstrated experimentally (21,43–49). Further, 35.57% of the total S/MARs were found to be located in the intergenic region (Figure 4A).…”
Section: Resultsmentioning
confidence: 66%
“…Notably, miR-222, miR-34a, miR-371a, Bax, Cyclin D1, NFκB, CD40, FN1 and PDGFRB genes showed presence of S/MAR within 1 Kb region upstream to their transcription start sites (TSS). Presence of S/MARs in the promoters of these genes has already been demonstrated experimentally (21,43–49). Further, 35.57% of the total S/MARs were found to be located in the intergenic region (Figure 4A).…”
Section: Resultsmentioning
confidence: 66%
“…A number of microRNAs, viz., miR-205, miR-383, miR-572, miR-371-373, miR-100, miR-32, miR-206, miR-147, miR-221/222, etc. playing diverse roles in cancer cell proliferation and metastasis, differentiation, epithelial to mesenchymal transition (EMT), inflammation and many other vital cellular functions have been predicted to be SMAR1 targets by ChIP-seq analysis 16 17 18 19 20 21 22 23 24 . Thus, our data suggests multi-faceted role of SMAR1 and projects new and unexplored pathways that SMAR1 might orchestrate globally.…”
Section: Resultsmentioning
confidence: 99%
“…We selected miRNAs that were highly expressed (within the top 10%, except for hsa-miR-320a). We selected miRNAs involved in different cell processes such as cancer (hsa-miR-17-92 cluster 52 , 53 and hsa-miR-21 53 55 ) and K562 differentiation (hsa-miR-223 56 , hsa-miR-103 57 , and hsa-miR-320a 57 , 58 ). The selected miRNAs were as follows: hsa-miR-20a (MIMAT0000075), hsa-miR-17 (MIMAT0000070), hsa-miR-19b (MIMAT0000074), hsa-miR-21 (MIMAT0000076), hsa-miR-92a (MIMAT0000092), hsa-miR-223 (MIMAT0000280), hsa-miR-25 (MIMAT0000081), hsa-miR-130b (MIMAT0000691), hsa-miR-103 (MIMAT0000101), and hsa-miR-320a (MIMAT0000510).…”
Section: Methodsmentioning
confidence: 99%